tiprankstipranks
Alzamend Neuro, Inc. (ALZN)
:ALZN
US Market

Alzamend Neuro (ALZN) Financial Statements

Compare
297 Followers

Alzamend Neuro Financial Overview

Alzamend Neuro's market cap is currently $5.54M. The company's EPS TTM is $-6.65; its P/E ratio is ―; Alzamend Neuro is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Jun 23Jun 22Jun 21Jun 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ -50.74K$ -23.07K$ 0.00$ 0.00$ 0.00
Operating Income$ -9.94M$ -14.87M$ -12.32M$ -4.95M$ -4.42M
EBITDA$ -9.89M$ -14.85M$ -12.32M$ 0.00$ 0.00
Net Income$ -9.95M$ -14.88M$ -12.40M$ -5.20M$ -4.40M
Balance Sheet
Cash & Short-Term Investments$ 376.05K$ 5.14M$ 14.06M$ 1.93M$ 90.28K
Total Assets$ 631.59K$ 5.92M$ 14.52M$ 2.91M$ 1.81M
Total Debt$ 300.71K$ 0.00$ 0.00$ 335.30K-
Net Debt$ -75.33K$ -5.14M$ -14.06M$ -1.59M-
Total Liabilities$ 3.23M$ 2.87M$ 1.16M$ 899.64K$ 992.31K
Stockholders' Equity$ -2.59M$ 3.05M$ 13.35M$ 2.01M$ 821.71K
Cash Flow
Free Cash Flow$ -8.42M$ -8.92M$ -6.72M$ -2.71M$ -2.35M
Operating Cash Flow$ -8.27M$ -8.92M$ -6.61M$ -2.71M$ -2.35M
Investing Cash Flow$ -147.24K$ 0.00$ -106.46K$ 100.92K$ 105.00K
Financing Cash Flow$ 3.65M$ 200.00$ 18.85M$ 4.45M$ 2.29M
Currency in USD

Alzamend Neuro Earnings and Revenue History

Alzamend Neuro Debt to Assets

Alzamend Neuro Cash Flow

Alzamend Neuro Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis